Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26

Published: 2026-05-08 13:35:06 ET NUS

Published on 05/08/2026 at 01:35 pm EDT

Dallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.6M, $6.8M, and $0.14, respectively. This compares to our estimates of $329.7M, $7.7M, and $0.15, respectively. Revenue came in near the low end of guidance, while adjusted EPS remained within range as management continued investing behind Prysm iO and emerging markets while maintaining cost discipline. Core Nu Skin gross margin improved 20 bps y/y to 76.9%, while adjusted operating margin was 3.6% versus 6.4% last year. The more important takeaway was management's commentary that brand affiliate confidence improved and new sales leaders grew y/y exiting the quarter, suggesting early field stabilization as Prysm iO training and leader engagement scale.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Click image above to view full announcement.

About StonegateStonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners (214) 987-4121 [email protected]

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296705